Silicon Laboratories Inc. (NASDAQ:SLAB - Get Free Report) has been given an average rating of "Moderate Buy" by the eleven ratings firms that are presently covering the company, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $136.20.
Several research firms have recently weighed in on SLAB. Needham & Company LLC raised their price objective on Silicon Laboratories from $140.00 to $150.00 and gave the stock a "buy" rating in a research note on Wednesday, February 5th. KeyCorp raised their price objective on Silicon Laboratories from $115.00 to $160.00 and gave the stock an "overweight" rating in a research note on Wednesday, January 22nd. Benchmark upgraded Silicon Laboratories from a "hold" rating to a "buy" rating and set a $160.00 target price for the company in a report on Wednesday, February 5th. Susquehanna initiated coverage on Silicon Laboratories in a report on Tuesday, December 17th. They issued a "neutral" rating and a $130.00 target price for the company. Finally, Morgan Stanley reduced their target price on Silicon Laboratories from $123.00 to $97.00 and set an "equal weight" rating for the company in a report on Tuesday, November 5th.
Read Our Latest Research Report on SLAB
Silicon Laboratories Stock Down 0.2 %
NASDAQ SLAB traded down $0.28 on Monday, reaching $150.44. 271,367 shares of the stock traded hands, compared to its average volume of 369,820. The firm's fifty day simple moving average is $132.69 and its 200 day simple moving average is $118.01. The company has a market cap of $4.88 billion, a price-to-earnings ratio of -25.33 and a beta of 1.16. Silicon Laboratories has a 12 month low of $94.00 and a 12 month high of $154.91.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its quarterly earnings data on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, hitting the consensus estimate of ($0.11). The business had revenue of $166.25 million during the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The company's revenue was up 91.4% compared to the same quarter last year. During the same period last year, the company posted ($1.19) EPS. As a group, equities research analysts forecast that Silicon Laboratories will post -0.47 EPS for the current fiscal year.
Insider Buying and Selling
In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of the firm's stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total transaction of $281,540.00. Following the transaction, the director now directly owns 32,115 shares in the company, valued at $4,520,828.55. This trade represents a 5.86 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Navdeep S. Sooch sold 2,360 shares of the firm's stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total value of $351,640.00. Following the transaction, the director now owns 400,567 shares in the company, valued at approximately $59,684,483. This trade represents a 0.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.72% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On Silicon Laboratories
Institutional investors have recently bought and sold shares of the stock. Franklin Resources Inc. raised its holdings in Silicon Laboratories by 1.9% during the third quarter. Franklin Resources Inc. now owns 231,889 shares of the semiconductor company's stock valued at $27,001,000 after buying an additional 4,278 shares in the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of Silicon Laboratories in the third quarter valued at about $7,408,000. Intech Investment Management LLC grew its position in shares of Silicon Laboratories by 82.9% in the third quarter. Intech Investment Management LLC now owns 12,837 shares of the semiconductor company's stock valued at $1,484,000 after purchasing an additional 5,818 shares during the last quarter. Barclays PLC grew its position in shares of Silicon Laboratories by 23.4% in the third quarter. Barclays PLC now owns 70,568 shares of the semiconductor company's stock valued at $8,157,000 after purchasing an additional 13,363 shares during the last quarter. Finally, Premier Fund Managers Ltd acquired a new stake in shares of Silicon Laboratories in the third quarter valued at about $934,000.
Silicon Laboratories Company Profile
(
Get Free ReportSilicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Featured Articles

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report